2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphedema
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leiomyoma
1
Keratosis, Actinic
1
Hodgkin Disease
1
Dermatitis, Contact
1
Dendritic Cell Sarcoma, Interdigitating
1
Chalazion
1
Carcinoma, Basal Cell
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Breast Cancer Lymphedema
1
Anemia, Refractory, with Excess of Blasts
1
Adenomyosis
1
Interventions
Fentanyl
27
Analgesia
23
Morphine
20
Acupuncture Therapy
18
Surveys and Questionnaires
16
Oxycodone
16
Zoledronic Acid
15
Acetaminophen
14
Therapeutics
13
Radiotherapy
13
Psychiatric Rehabilitation
13
Ketamine
13
Methadone
11
Lidocaine
11
Hydromorphone
11
Bupivacaine
11
nabiximols
10
Ibandronic Acid
10
Ropivacaine
9
Early Intervention, Educational
7
Analgesics, Opioid
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Triamcinolone
×
Clear all
NCT02025023
2020-02-06
CTS
University of Washington
Phase 3
Recruiting
120 enrolled